Where does Cambrian Bio's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Cambrian Bio's 1 recorded funding rounds.

Premier Alternatives

Cambrian Bio

Drug Discovery · New York, NY · Founded 2019 · Privately Held (backing)

Developer of a portfolio of medicines designed to target the causes of age-related diseases. Cambrian Bio is based in New York, NY and was founded in 2019. Its last reported valuation was $180 million in Aug 2023. It has raised $204 million across 1 recorded round; the latest was a $23.8 million later-stage round in Dec 2025.

Last reported valuation

$180.0M

Oct 2026

Priced at

—

Total raised

$204.1M

Last round

Later Stage VC

Dec 2025

Cap table — not yet on record

Cambrian Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Cambrian Bio with a free account

·The complete investor list: 41 names
·Watch Cambrian Bio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Cambrian Bio

Where does Cambrian Bio's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Cambrian Bio's 1 recorded funding rounds.